Douglas S. Hawkins

Also affiliated with University of Washington, Seattle Children's Hospital, Children's Oncology Group

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.0Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma

JCO Precision Oncology(2021)10.1200/po.20.00218

Top 16%

1.3DataRank

Top 16%45 citations

Nicholas Light, Vallijah Subasri, Erin L. Young, Talía Wegman-Ostrosky, Donald A. Barkauskas +21 more

Papers

Driven by 40 papers — median percentile 20. Top paper: “SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma”.

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma

Cancer(2020)10.1002/cncr.33349

N/A

1.4DataRank · unranked

47 citations

Karla V. Ballman, Lee J. Helman, Shreyaskumar Patel, Jeremy Whelan, Brigitte C. Widemann +9 more

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma

JCO Precision Oncology(2021)10.1200/po.20.00218

Top 16%

1.3DataRank

Top 16%45 citations

Nicholas Light, Vallijah Subasri, Erin L. Young, Talía Wegman-Ostrosky, Donald A. Barkauskas +21 more

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group

The Lancet Oncology(2024)10.1016/s1470-2045(24)00255-9

N/A

0.907DataRank · unranked

43 citations

Wei Xue, Douglas J Harrison, Douglas S. Hawkins, Roshni Dasgupta, Suzanne Wolden +10 more

Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa204

N/A

0.705DataRank · unranked

109 citations

Saumya D. Sisoudiya, Bailey A. Martin‐Giacalone, Michael M. Khayat, Shannon Dugan‐Perez, Deborah A. Marquez-Do +16 more

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3009

N/A

0.518DataRank · unranked

16 citations

Amit J. Sabnis, Paul M. Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy

Scientific Reports(2023)10.1038/s41598-023-39357-2

N/A

0.471DataRank · unranked

11 citations

Liting Zhou, Disheet Shah, Romina B. Cejas, David K. Crossman, Mariam Jouni +18 more

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10009

N/A

0.464DataRank · unranked

21 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G

The Oncologist(2024)10.1093/oncolo/oyae119

N/A

0.363DataRank · unranked

7 citations

AeRang Kim, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10008

N/A

0DataRank · unranked

2 citations

Olive S. Eckstein, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1663

N/A

0DataRank · unranked

28 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis

European Journal of Cancer(2022)10.1016/j.ejca.2022.03.022

N/A

0DataRank · unranked

31 citations

Rajkumar Venkatramani, Anton Schönstein, Svetlana Pack, Rita Alaggio, Christian Vokuhl +13 more

Do children and adolescents with completely resected alveolar rhabdomyosarcoma require adjuvant radiation? A report from the Children's Oncology Group

Pediatric Blood & Cancer(2020)10.1002/pbc.28243

N/A

0DataRank · unranked

9 citations

Yueh‐Yun Chi, Jing Tian, Erin R. Rudzinski, Odion Binitie, Roshni Dasgupta +4 more

Outcomes following preoperative chemoradiation +/- pazopanib in non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): A report from Children's Oncology Group (COG) and NRG Oncology.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11504

N/A

0DataRank · unranked

8 citations

Yen‐Lin Chen, Thomas J. Scharschmidt, Wei Xue, Zhengya Gao, Jennifer O. Black +15 more

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad085

N/A

0DataRank · unranked

95 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3334

N/A

0DataRank · unranked

59 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Children's Oncology Group's 2023 blueprint for research

Pediatric Blood & Cancer(2023)10.1002/pbc.30569

N/A

0DataRank · unranked

16 citations

Lia Gore, Douglas S. Hawkins

Rare tumors: Opportunities and challenges from the Children’s Oncology Group perspective

EJC Paediatric Oncology(2023)10.1016/j.ejcped.2023.100024

N/A

0DataRank · unranked

11 citations

Murali Chintagumpala, Jin Piao, Kenneth S. Chen, Rachana Shah, Robyn D. Gartrell +15 more

Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children’s Oncology Group

Scientific Reports(2020)10.1038/s41598-020-69015-w

N/A

0DataRank · unranked

47 citations

Valentin Dinu, Xiyuan Zhang, Haiyan Lei, Jack F. Shern, Jin Hyoung Park +10 more

Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children’s Oncology Group

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad055

N/A

0DataRank · unranked

4 citations

Melissa A. Richard, Michael E. Scheurer, Javed Khan, Pagna Sok, Priya B. Shetty +17 more

Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10007

N/A

0DataRank · unranked

20 citations

Alexander J. Chou, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10006

N/A

0DataRank · unranked

4 citations

Rajen Mody, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo +14 more

Polygenic risk of anthracycline-related cardiomyopathy in childhood cancer survivors: Report from children’s oncology group and childhood cancer survivor study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12090

N/A

0DataRank · unranked

1 citations

Xuexia Wang, Fan Wang, Purnima Singh, Liting Zhou, Wendy Landier +15 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v1

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Data from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

(2023)10.1158/1078-0432.c.6532878.v1

N/A

0DataRank · unranked

0 citations

Hyun Jung, G. Thomas Brown, Yanling Liu, Ben Somerville, Curtis Lisle +20 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v2

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group

Cancer(2020)10.1002/cncr.33275

N/A

0DataRank · unranked

45 citations

Yueh‐Yun Chi, Minjie Li, Suzanne L. Wolden, Dana L. Casey, Jonathan C. Routh +7 more

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4170

N/A

0DataRank · unranked

13 citations

He Li, Michael E. Scheurer, Dana L. Casey, Shannon Dugan‐Perez, Deborah A. Marquez-Do +19 more

Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with 4hydroxycyclophosphamide formation in children with Cancer

Cancer Chemotherapy and Pharmacology(2024)10.1007/s00280-024-04703-2

N/A

0DataRank · unranked

2 citations

Navin Pinto, Douglas S. Hawkins, Julie R. Park, Saam Dilmaghani, Christine F. Rimorin +3 more

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

UNC Libraries(2024)10.17615/m7sp-3e70

N/A

0DataRank · unranked

0 citations

Shannon Dugan‐Perez, Michael E. Scheurer, Sharon E. Plon, Brian D. Crompton, Philip J. Lupo +19 more

Enrollment in Children’s Oncology Group’s clinical trials: population-based linkage with the National Childhood Cancer Registry

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf134

N/A

0DataRank · unranked

6 citations

David A. Siegel, Nicola Schussler, Todd A. Alonzo, Suzanne Adams, David Angelaszek +20 more

Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration

European Journal of Cancer(2025)10.1016/j.ejca.2025.115629

N/A

0DataRank · unranked

4 citations

Susan Chi, Theodore W Laetscht, Lynley V. Marshall, Elizabeth A. Raetz, Rani E. George +34 more

Alternative mRNA splicing in anthracycline-induced cardiomyopathy – a COG-ALTE03N1 report

Cardio-Oncology(2025)10.1186/s40959-025-00345-2

N/A

0DataRank · unranked

2 citations

David K. Crossman, Changde Cheng, Patrick J. Trainor, Noha Sharafeldin, Xuexia Wang +12 more

Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups

Pediatric Blood & Cancer(2020)10.1002/pbc.28832

N/A

0DataRank · unranked

29 citations

Yueh‐Yun Chi, Gian Luca De Salvo, Minjie Li, Johannes H. M. Merks, David A. Rodeberg +15 more

The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children’s Oncology Group

Human Genetics and Genomics Advances(2025)10.1016/j.xhgg.2025.100466

N/A

0DataRank · unranked

0 citations

Christina L. Magyar, Bailey A. Martin‐Giacalone, Michael E. Scheurer, Deborah A. Marquez-Do, Mark Zobeck +17 more

Maximum tumor dimension and tumor volume as prognostic factors in patients with newly diagnosed localized Ewing sarcoma (ES)- a report from the Children’s Oncology Group (COG).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11529

N/A

0DataRank · unranked

4 citations

Allen Buxton, Steven G. DuBois, Dian Wang, Nadia N. Laack, Kenneth L. Brown +15 more

Survival outcomes of patients with localized FOXO1 fusion‐positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Cancer(2020)10.1002/cncr.33334

N/A

0DataRank · unranked

36 citations

Yueh‐Yun Chi, Rajkumar Venkatramani, Minjie Li, Michael Arnold, Roshni Dasgupta +4 more

Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10007

N/A

0DataRank · unranked

3 citations

Katherine A. Janeway, David R. Patton, Jennifer Lee, Brent Coffey, P. Mickey Williams +16 more

Douglas S. Hawkins

Indexed papers

Top data-sharing exemplar

Papers